Choreo LLC’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,941
Closed -$258K 1782
2026
Q1
$258K Sell
4,941
-1,770
-26% -$106K ﹤0.01% 1342
2025
Q4
$397K Sell
6,711
-732
-10% -$44.5K 0.01% 1040
2025
Q3
$414K Buy
7,443
+2,083
+39% +$112K 0.01% 1029
2025
Q2
$276K Buy
+5,360
New +$269K ﹤0.01% 1232
2025
Q1
Sell
-4,812
Closed -$348K 1595
2024
Q4
$348K Buy
4,812
+603
+14% +$44.3K 0.01% 1101
2024
Q3
$329K Sell
4,209
-102
-2% -$7.67K ﹤0.01% 1152
2024
Q2
$309K Buy
+4,311
New +$317K 0.01% 1085
2022
Q2
Sell
-20,000
Closed -$2.17M 243
2022
Q1
$2.17M Buy
+20,000
New +$2.06M 0.11% 58

Other funds holding TECH

Choreo LLC's TECH Position: Q2 2026 in Review

Choreo LLC sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 4,941 shares — an estimated $258K sold.

Choreo LLC first reported a position in TECH in Q1 2022 and held it in 8 quarters. The position peaked at $2.17M in Q1 2022. 596 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Choreo LLC reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Choreo LLC sold 4,941 Bio-Techne shares in Q2 2026, an estimated $258K.
  • Choreo LLC first reported a position in Bio-Techne in Q1 2022 and held it in 8 quarters.
  • Choreo LLC's Bio-Techne position peaked at $2.17M in Q1 2022.
  • 596 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Choreo LLC's 13F filing for Q2 2026, filed 4 Aug 2026.